Skip to content

Home
Artificial intelligence
Biotechnology
Genetics
Medical Technology

Home
Uncategorized
Sagimet rises as licensing deal with Teva unit targets Madrigal drug

Sagimet rises as licensing deal with Teva unit targets Madrigal drug

Dec 17, 2025

Post navigation

John Paul DeJoria Joins PhytoTeq as Advisor and Investor to Champion a Healthier, More Sustainable Future for Food

More pharmas expected to sign drug pricing deals with Trump on Friday – report

PR Newswire
GlobeNewswire

Contact
Privacy Policy

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

Search for: